Cumberland Pharmaceuticals Inc.: shareholders and insiders

CPIXNASDAQHealthcare · Pharmaceutical Preparations

Price

$5.91

November 16, 2026Market cap $88M

What Ploutos Investor adds for Cumberland Pharmaceuticals

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 25% since Aug 7, 2026, when the 10-Q these figures come from was filed ($7.80 then, $5.88 on Nov 13, 2026). The figures date from before that move.10-Q
  • The reported profit is far larger than a business usually earns on its market value, which usually means one-off or accounting gains. We leave out the P/E and the earnings yield.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Sorry, we do not have enough data

for purchases and sales by Cumberland Pharmaceuticals's insiders

Why?

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

1 Holders over 5%Feb 9, 2026 Latest filing
  • A.J. Kazimi
    Share of class38.4%
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Integrated Core Strategies (US) LLC4.00%Oct 30, 202513G/A
  • Ikarian Capital, LLC4.90%May 15, 202513G

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter+341%
  • Renaissance Technologies
    In the quarter-11%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 2.25% of its shares outstanding were held short, -3.7% since the report before.

Shares held short
336.0K
2.25%
Since the report before348.9K on Sep 30, 2026
-3.7%
9.0
37.4K
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 25.0K
  • Nov 15, 2023: Shares held short 18.6K
  • Nov 30, 2023: Shares held short 20.1K
  • Dec 15, 2023: Shares held short 18.1K
  • Dec 29, 2023: Shares held short 19.1K
  • Jan 12, 2024: Shares held short 38.3K
  • Jan 31, 2024: Shares held short 31.9K
  • Feb 15, 2024: Shares held short 28.7K
  • Feb 29, 2024: Shares held short 23.9K
  • Mar 15, 2024: Shares held short 20.4K
  • Mar 28, 2024: Shares held short 17.0K
  • Apr 15, 2024: Shares held short 17.3K
  • Apr 30, 2024: Shares held short 18.3K
  • May 15, 2024: Shares held short 29.2K
  • May 31, 2024: Shares held short 19.7K
  • Jun 14, 2024: Shares held short 26.0K
  • Jun 28, 2024: Shares held short 16.8K
  • Jul 15, 2024: Shares held short 16.7K
  • Jul 31, 2024: Shares held short 15.5K
  • Aug 15, 2024: Shares held short 9,832
  • Aug 30, 2024: Shares held short 8,126
  • Sep 13, 2024: Shares held short 12.3K
  • Sep 30, 2024: Shares held short 15.4K
  • Oct 15, 2024: Shares held short 40.5K
  • Oct 31, 2024: Shares held short 76.7K
  • Nov 15, 2024: Shares held short 89.6K
  • Nov 29, 2024: Shares held short 164.3K
  • Dec 13, 2024: Shares held short 1.47M
  • Dec 31, 2024: Shares held short 478.4K
  • Jan 15, 2025: Shares held short 438.8K
  • Jan 31, 2025: Shares held short 191.6K
  • Feb 14, 2025: Shares held short 500.7K
  • Feb 28, 2025: Shares held short 313.6K
  • Mar 14, 2025: Shares held short 293.2K
  • Mar 31, 2025: Shares held short 226.0K
  • Apr 15, 2025: Shares held short 141.4K
  • Apr 30, 2025: Shares held short 86.2K
  • May 15, 2025: Shares held short 79.0K
  • May 30, 2025: Shares held short 62.7K
  • Jun 13, 2025: Shares held short 68.1K
  • Jun 30, 2025: Shares held short 8,532
  • Jul 15, 2025: Shares held short 6,441
  • Jul 31, 2025: Shares held short 21.2K
  • Aug 15, 2025: Shares held short 53.6K
  • Aug 29, 2025: Shares held short 52.8K
  • Sep 15, 2025: Shares held short 45.0K
  • Sep 30, 2025: Shares held short 54.6K
  • Oct 15, 2025: Shares held short 53.4K
  • Oct 31, 2025: Shares held short 49.7K
  • Nov 14, 2025: Shares held short 34.1K
  • Nov 28, 2025: Shares held short 24.5K
  • Dec 15, 2025: Shares held short 30.6K
  • Dec 31, 2025: Shares held short 140.7K
  • Jan 15, 2026: Shares held short 100.8K
  • Jan 30, 2026: Shares held short 76.1K
  • Feb 13, 2026: Shares held short 193.2K
  • Feb 27, 2026: Shares held short 180.8K
  • Mar 13, 2026: Shares held short 142.8K
  • Mar 31, 2026: Shares held short 109.7K
  • Apr 15, 2026: Shares held short 112.9K
  • Apr 30, 2026: Shares held short 523.4K
  • May 15, 2026: Shares held short 454.8K
  • May 29, 2026: Shares held short 354.9K
  • Jun 15, 2026: Shares held short 338.8K
  • Jun 30, 2026: Shares held short 242.4K
  • Jul 15, 2026: Shares held short 372.7K
  • Jul 31, 2026: Shares held short 386.5K
  • Aug 14, 2026: Shares held short 326.2K
  • Aug 31, 2026: Shares held short 274.7K
  • Sep 15, 2026: Shares held short 252.5K
  • Sep 30, 2026: Shares held short 348.9K
  • Oct 15, 2026: Shares held short 336.0K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading43.0% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 43.0% of the shares in the reported trades were short sales, against 44.3% in the 14 before.

Last 14 sessionsOct 27, 2026 – Nov 13, 2026
43.0%
The 14 beforeOct 7, 2026 – Oct 26, 2026
44.3%
Change
-1.3 pts
Short sales a dayon average, of 145.1K shares
62.4K
More than atof 3,649 US-listed companies, same days
28%
Median of alleight in ten from 34.6% to 63.4%
50.1%
  • Oct 7, 2026: Short sales 28.6%
  • Oct 8, 2026: Short sales 45.4%
  • Oct 9, 2026: Short sales 62.2%
  • Oct 12, 2026: Short sales 51.2%
  • Oct 13, 2026: Short sales 90.2%
  • Oct 14, 2026: Short sales 34.3%
  • Oct 15, 2026: Short sales 25.2%
  • Oct 16, 2026: Short sales 44.3%
  • Oct 19, 2026: Short sales 24.2%
  • Oct 20, 2026: Short sales 42.8%
  • Oct 21, 2026: Short sales 34.9%
  • Oct 22, 2026: Short sales 64.9%
  • Oct 23, 2026: Short sales 56.4%
  • Oct 26, 2026: Short sales 50.9%
  • Oct 27, 2026: Short sales 31.3%
  • Oct 28, 2026: Short sales 16.4%
  • Oct 29, 2026: Short sales 44.5%
  • Oct 30, 2026: Short sales 66.7%
  • Nov 2, 2026: Short sales 18.1%
  • Nov 3, 2026: Short sales 37.5%
  • Nov 4, 2026: Short sales 28.4%
  • Nov 5, 2026: Short sales 42.4%
  • Nov 6, 2026: Short sales 44.9%
  • Nov 9, 2026: Short sales 40.9%
  • Nov 10, 2026: Short sales 40.8%
  • Nov 11, 2026: Short sales 68.2%
  • Nov 12, 2026: Short sales 42.1%
  • Nov 13, 2026: Short sales 49.7%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

6.07M Insiders' shares40.56% Of the company
  • A J KazimiChairman and CEO
    Directly5.70M
  • Kenneth KrogulskiDirector
    Directly289.7K
  • James JonesDirector
    Directly43.9K
  • Caroline YoungDirector
    Directly32.9K

A lower bound: it counts only the 4 officers and directors with a market trade since Nov 17, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

3 ETFs holding it0.00% The largest weight (VXF)
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%
  • DFACDimensional U.S. Core Equity 2 ETF
    Weight in the fund0.00%

3 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

32 Managers, Q2 2026$16M Value of their positions
  • Q3 2025: Managers 30
  • Q4 2025: Managers 27
  • Q1 2026: Managers 29
  • Q2 2026: Managers 32

Institutional investors by quarter

The fund managers holding CPIX, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 32 managers held 2.47M shares, worth $16M. During the quarter 8 opened a position, 5 closed one, 8 added and 7 trimmed.

The largest holders, Q2 2026

  • Ikarian Capital
    In the quarter-9.0%
  • Renaissance Technologies
    In the quarter+1.6%
  • Vanguard Capital Management
    In the quarter+4.9%
  • Dimensional Fund Advisors
    In the quarter-16%
  • Boothbay Fund Management
    In the quarter-12%
  • Geode Capital Management
    In the quarter-5.1%
  • Perceptive Advisors
    In the quarter-51%
  • Citadel Advisors (Griffin)
    In the quarter+341%
  • BlackRock
    In the quarter+12%
  • Bank of New York Mellon
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Cumberland Pharmaceuticals's filings show?

Who buys and sells is one part of Cumberland Pharmaceuticals's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CPIX's shareholders

Didn't find what you were looking for?

Ask us
Have CPIX's insiders bought or sold?

From – to – Cumberland Pharmaceuticals's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold CPIX?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $3.3M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.